Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis
- Conditions
- Endometrial Cancer
- Registration Number
- NCT04251676
- Lead Sponsor
- National Taiwan University Hospital
- Brief Summary
We wish to study radiation therapy in uterine cancer, focusing on dosimetry analysis, clinical implication, and survival analysis.
- Detailed Description
We wish to study radiation therapy in uterine cancer, focusing on dosimetry analysis, clinical implication, and survival analysis.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
- Women with uterine cancer (stage I - IV) treated in National Taiwan University Hospital, from January 2010 to September 2019.
Read More
Exclusion Criteria
- Women with uterine cancer (stage I - IV) NOT treated in National Taiwan University Hospital, from January 2010 to September 2019.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival 5 years Progression free survival: The time from inclusion to documented disease progression according to RECIST v1.1 or death from any cause.
- Secondary Outcome Measures
Name Time Method